Phase II study of clofarabine in pediatric patients with refractory or relapsed acute myeloid leukemia Academic Article uri icon

Overview

MeSH Major

  • Adenine Nucleotides
  • Arabinonucleosides
  • Leukemia, Myeloid

abstract

  • Clofarabine is active in pediatric patients with multiply relapsed or refractory AML. Responses allowed several refractory patients to proceed to HSCT. The toxicity profile was expected in this patient population.

publication date

  • September 10, 2009

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC2744276

Digital Object Identifier (DOI)

  • 10.1200/JCO.2008.18.8706

PubMed ID

  • 19652076

Additional Document Info

start page

  • 4392

end page

  • 7

volume

  • 27

number

  • 26